Delivery Order SPE2DB22D3004-SPE2DB25FSH54
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,755.64 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count packages) under a firm fixed-price contract valued at $1,649.05. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen will perform this contract from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1.75K to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order, issued on August 1, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Qulipta 60 mg tablets in a quantity of 30 units, with a contract ceiling value of $1,154.79. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $7,481.34 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count supply) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) on October 16, 2025, with a ceiling value of $1,743.64 and an ultimate completion date of October 17, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets in a quantity of 30 units, valued at $7,459.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (quantity 30) under a firm fixed-price contract valued at $3,592.48. The order was competitively awarded without set-aside designation and is scheduled for completion by September 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,154.79 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through...
- The Defense Logistics Agency awarded a delivery order valued at $16,651.42 to AmerisourceBergen Drug Corp for the supply of Qulipta 60 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price contract represents a competitively awarded delivery order with no set-aside designation. The award is fulfilled by AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a critical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH54Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count) under a firm fixed-price contract valued at $10,801.96, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive procurement of pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for the Defense Logistics Agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The delivery order for Qulipta represents one of many firm fixed-price transactions executed under this master contract vehicle, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 9/5/25 |